Kate S. Ashton

1.1k total citations
9 papers, 169 citations indexed

About

Kate S. Ashton is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Kate S. Ashton has authored 9 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Surgery and 1 paper in Organic Chemistry. Recurrent topics in Kate S. Ashton's work include Pancreatic function and diabetes (3 papers), Ubiquitin and proteasome pathways (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Kate S. Ashton is often cited by papers focused on Pancreatic function and diabetes (3 papers), Ubiquitin and proteasome pathways (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Kate S. Ashton collaborates with scholars based in United States, India and United Kingdom. Kate S. Ashton's co-authors include David J. St. Jean, Jaeki Min, Huan Rui, Connie W. Wang, Patrick Ryan Potts, Mark H. Norman, Edward Rosser, Jie Yan, Simon Morton and Matthew P. Bourbeau and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Kate S. Ashton

9 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate S. Ashton United States	6	106	78	27	23	16	9	169
Anita J. Kempf-Grote United States	6	108 1.0×	110 1.4×	44 1.6×	18 0.8×	10 0.6×	6	244
Jeffrey Varnes United States	11	97 0.9×	122 1.6×	46 1.7×	31 1.3×	7 0.4×	20	260
Iain M. McDonald United Kingdom	12	145 1.4×	146 1.9×	44 1.6×	13 0.6×	30 1.9×	14	292
Hiroshi Sakashita Japan	9	88 0.8×	76 1.0×	91 3.4×	20 0.9×	7 0.4×	16	225
Stéphane Ciblat France	10	104 1.0×	193 2.5×	48 1.8×	15 0.7×	12 0.8×	18	294
Tammy C. Wang United States	10	98 0.9×	113 1.4×	17 0.6×	22 1.0×	4 0.3×	16	278
Stéphane Raeppel France	10	81 0.8×	185 2.4×	31 1.1×	23 1.0×	3 0.2×	21	258
Qiao Sun China	7	154 1.5×	138 1.8×	34 1.3×	6 0.3×	9 0.6×	8	311
Yuri Bukhtiyarov United States	9	118 1.1×	46 0.6×	19 0.7×	8 0.3×	9 0.6×	17	179
Anita Dellsèn Sweden	8	125 1.2×	47 0.6×	13 0.5×	5 0.2×	13 0.8×	10	196

Countries citing papers authored by Kate S. Ashton

Since Specialization

Citations

This map shows the geographic impact of Kate S. Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate S. Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate S. Ashton more than expected).

Fields of papers citing papers by Kate S. Ashton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate S. Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate S. Ashton. The network helps show where Kate S. Ashton may publish in the future.

Co-authorship network of co-authors of Kate S. Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of Kate S. Ashton. A scholar is included among the top collaborators of Kate S. Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate S. Ashton. Kate S. Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Li, Shiqian, et al.. (2025). VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation. Cell chemical biology. 32(3). 423–433.e9. 3 indexed citations

Nalawansha, Dhanusha A., Kate S. Ashton, Weixian Deng, et al.. (2025). LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradation. Nature Communications. 16(1). 7812–7812. 2 indexed citations

Rui, Huan, Kate S. Ashton, Jaeki Min, Connie W. Wang, & Patrick Ryan Potts. (2023). Protein–protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction. RSC Chemical Biology. 4(3). 192–215. 44 indexed citations

Ashton, Kate S., et al.. (2014). A general method for the facile synthesis of optically active 2-substituted piperazines via functionalized 2,5-diketopiperazines. Tetrahedron Letters. 55(32). 4501–4504. 10 indexed citations

Hong, Fang‐Tsao, Mark H. Norman, Kate S. Ashton, et al.. (2014). Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 4. Exploration of a Novel Binding Pocket. Journal of Medicinal Chemistry. 57(14). 5949–5964. 10 indexed citations

Bourbeau, Matthew P., Kate S. Ashton, Jie Yan, & David J. St. Jean. (2014). Nonracemic Synthesis of GK–GKRP Disruptor AMG-3969. The Journal of Organic Chemistry. 79(8). 3684–3687. 21 indexed citations

Nishimura, Nobuko, Mark H. Norman, Longbin Liu, et al.. (2014). Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 3. Structure–Activity Relationships within the Aryl Carbinol Region of the N-Arylsulfonamido-N′-arylpiperazine Series. Journal of Medicinal Chemistry. 57(7). 3094–3116. 47 indexed citations

Ashton, Kate S., David J. St. Jean, Steve F. Poon, et al.. (2011). Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2. Bioorganic & Medicinal Chemistry Letters. 21(18). 5191–5196. 5 indexed citations

Rosser, Edward, Simon Morton, Kate S. Ashton, Philip Cohen, & Alison N. Hulme. (2003). Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways. Organic & Biomolecular Chemistry. 2(1). 142–142. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact